Responses
Coronary artery disease
Original research article
Serum PCSK9 is modified by interleukin-6 receptor antagonism in patients with hypercholesterolaemia following non-ST-elevation myocardial infarction
Compose a Response to This Article
Other responses
No responses have been published for this article.